Literature DB >> 1974943

Recurrent lesions in human Leishmania braziliensis infection--reactivation or reinfection?

N G Saravia1, K Weigle, I Segura, S H Giannini, R Pacheco, L A Labrada, A Goncalves.   

Abstract

Strains of Leishmania braziliensis subspecies isolated from initial and recurrent lesions in 24 patients from the Pacific coast of Colombia were examined for distinguishing polymorphisms by enzyme electrophoresis, restriction endonuclease analysis of kDNA, and molecular karyotyping of nuclear DNA. Recurrent strains from 12 patients (50%) were identical to the initially infecting strain by all methods of characterisation. Phenotypic and genotypic identity, together with clinical data, support endogenous reactivation as the mechanisms of recurrent disease in these 12 patients. 5 of the 24 (22%) recurrent strains differed from the initial strain by all methods. The remaining 7 strain pairs, not separated by enzyme polymorphisms, showed differing schizodeme and/or karyotype profiles. Patients whose recurrent lesions were caused by strains different from those causing the initial lesions had a significantly longer disease-free interval than patients whose lesions were caused by identical strains. Recurrent lesions occurred further from initial lesions in the former than in the latter group. Exogenous reinfection is the most plausible explanation for recurrences due to disparate organisms. These findings have important implications for both treatment evaluation and vaccination strategies for American tegumentary leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974943     DOI: 10.1016/0140-6736(90)91945-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 2.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 3.  Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Quantitative Kinetoplast DNA Assessment During Treatment of Mucosal Leishmaniasis as a Potential Biomarker of Outcome: A Pilot Study.

Authors:  Marlene Jara; Braulio Mark Valencia; Vanessa Adaui; Milena Alba; Rachel Lau; Jorge Arevalo; Alejandro Llanos-Cuentas; Andrea K Boggild
Journal:  Am J Trop Med Hyg       Date:  2015-10-19       Impact factor: 2.345

Review 5.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species.

Authors:  Yira Rosalba Díaz; Ricardo Rojas; Liliana Valderrama; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

7.  Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity.

Authors:  C R Davies; E A Llanos-Cuentas; S D Pyke; C Dye
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

8.  Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.

Authors:  A Lucumi; S Robledo; V Gama; N G Saravia
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 9.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 10.  [Cutaneous leishmaniasis].

Authors:  C D Enk; K Gardlo; M Hochberg; A Ingber; T Ruzicka
Journal:  Hautarzt       Date:  2003-04-18       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.